Document:

ex_259874.htm

 

Exhibit 10.1

 

AVAILABILITY RETAINER AGREEMENT

 

This Availability Retainer Agreement (“Agreement”) is entered into as of June 24, 2021 (“Effective Date”), by and between BioSig Technologies, Inc. (the “Company”) and Jeffrey O’Donnell (the “Contractor”).

 

WITNESSETH:

 

WHEREAS, the Contractor was a member of the Company’s Board of Directors;

 

WHEREAS, the Company desires to continue to engage the services of the Contractor; and

 

WHEREAS, the Contractor desires to accept such engagement, upon the terms and subject to the conditions set forth in this Agreement;

 

NOW, THEREFORE, for and in consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby expressly acknowledged by the parties, the parties agree as follows:

 

1.         Contract Term. The Company agrees to retain the Contractor and the Contractor agrees to serve as a contractor to the Company in accordance with this Agreement commencing on the Effective Date and continuing for a period of twelve (12) months (the “Term”). Notwithstanding the foregoing, the Company may terminate the Agreement and the Term immediately upon the Contractor’s breach of this Agreement.

 

2.         Services Provided. The Contractor agrees to make himself available to dutifully provide to the Company services for up to twenty (20) hours per month on an as-needed basis as determined in the sole discretion of the Company, concerning the matters and responsibilities as are reasonably requested by the Company, including, without limitation, his guidance on the Company’s scientific and strategic initiatives. For the avoidance of any doubt, the parties agree that the Company may not require and/or have a need for the Contractor to provide any services during any applicable month during the Term and the Contractor shall nonetheless still receive the applicable compensation set forth hereunder.

 

3.         Compensation. The Company agrees to pay the Contractor during the Term $17,000 per month, in arrears. As an independent contractor, the Contractor will be responsible for payment of all taxes and required state and federal withholdings. The Company will provide an IRS form 1099 to the Contractor as required by law.

 

4.         Federal, State, and Local Taxes. Neither federal, state, or local income tax nor payroll tax of any kind shall be withheld or paid by the Company on behalf of the Contractor. The Contractor shall not be treated as an employee with respect to services performed under the Agreement for federal, state, or local tax purposes.

 

PAGE 1 OF 3

 

 

5.         Notices to the Contractor About Tax Duties and Liabilities. The Contractor understands that he is responsible to pay, according to the applicable law, the Contractor’s income taxes. The Contractor further understands that the Contractor may be liable for self-employment tax to be paid by the Contractor according to the law. The parties agree that any tax consequences or liability arising from the Company’s payments to the Contractor shall be the sole responsibility of the Contractor. Should any state or federal taxing authority determine that any of the payments hereunder constitute income subject to withholding under any federal or state law, then the Contractor agrees to indemnify and hold the Company harmless for any and all tax liability, including, but not limited to, taxes, levies, assessments, fines, interest, costs, expenses, penalties, and attorneys’ fees.

 

6.         Benefits. The Contractor shall at all times be an independent contractor (and not an employee or agent of the Company); therefore, the Contractor shall not be entitled to participate in any benefit plans or programs that the Company provides or may provide to its employees.

 

7.         Reimbursement and Business Expenses. The Company shall not be liable to the Contractor for any expenses paid or incurred by the Contractor unless agreed to in writing.

 

8.         Workers’ Compensation. The Contractor understands and acknowledges that the Company shall not obtain workers’ compensation insurance covering the Contractor.

 

10.         Confidential Matters and Proprietary Information. All confidential information which the Contractor may now possess, may obtain during or after the Term, or may create prior to the end of the Term relating to the business of the Company or of any customer or supplier of the Company shall not be published, disclosed or made accessible by him to any other person, firm or corporation either during or after the termination of the Term. The Contractor shall return all tangible evidence of such confidential information to the Company prior to or at the termination of the Term.

 

11.         Independent Contractor Status. It is expressly agreed and understood by the parties that:

 

(a)         nothing in this Agreement shall be deemed to create or imply an agency or employment relationship between Contractor and the Company;

 

(b)         the status of the Contractor under the Agreement shall be that of solely an independent contractor and the Contractor shall be solely responsible for his own actions and/or inactions; and

 

(c)         Contractor shall neither act nor represent himself as an agent or employee of the Company to any person or entity.

 

The Company acknowledges that the Contractor may provide similar or dissimilar services to others, and nothing in this Agreement shall be construed to limit the Contractor’s right, individually or through a company, partnership or other entity, to provide services to others during the Term of this Agreement or at any other time.

 

PAGE 2 OF 3

 

 

12.         Entire Agreement, Amendment, Binding Effect. This Agreement constitutes the entire agreement between the parties concerning the parties’ consulting arrangement. No changes in or additions to this Agreement shall be recognized unless incorporated herein by written amendment, such amendment to become effective on the date stipulated therein.

 

13.         Controlling Law. This Agreement shall be governed by and construed under the laws of the State of Delaware, without regard to any applicable conflict of law or choice of law rules. Venue of any litigation arising from this Agreement shall be in the United States District Court for the District of Delaware, or a state district court of competent jurisdiction in New Castle County, Delaware. The Contractor consents to personal jurisdiction of the United States District Court for the District of Delaware, or a state district court of competent jurisdiction in New Castle County, Delaware for any dispute relating to or arising out of this Agreement, and agrees that Contractor shall not challenge personal jurisdiction in such courts. The Contractor waives any objection that the Contractor may now or hereafter have to the venue or jurisdiction of any proceeding in such courts or that any such proceeding was brought in an inconvenient forum (and agrees not to plead or claim the same).

 

14.         Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original. The parties agree that a fully executed photocopy of this Agreement shall be valid as an original.

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the Effective Date.

 

 

Company:

 

BioSig Technologies, Inc.

 

/s/ Kenneth L. Londoner

By:            Kenneth L. Londoner

Title:         Chairman and Chief Executive Officer

 

 

Contractor:

 

Jeffrey O’Donnell

 

/s/ Jeffrey O’Donnell

 

PAGE 3 OF 3Exhibit 10.3

 

STOCK
APPRECIATION RIGHTS AGREEMENT

PURSUANT TO THE

SOMALOGIC, INC. 2021 OMNIBUS INCENTIVE PLAN

 

*
* * * *

 

Participant:
_____________________

Grant
Date: _____________________

Base
Price: $_____

Number
of Shares subject to this SAR: _____________________

 

*
* * * *

 

THIS
STOCK APPRECIATION RIGHTS AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into
by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant
to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which
is administered by the Committee; and

 

WHEREAS,
it has been determined under the Plan that it would be in the best interests of the Company to grant the Stock Appreciation Rights (“SAR”)
provided for herein to the Participant.

 

NOW,
THEREFORE, in consideration of the mutual covenants and promises hereinafter set forth and for other good and valuable consideration,
the parties hereto hereby mutually covenant and agree as follows:

 

1. Incorporation
By Reference; Plan Document Receipt. This Agreement is subject in all respects to the terms and provisions of the Plan (including,
without limitation, any amendments thereto adopted at any time and from time to time unless such amendments are expressly intended not
to apply to the Award provided hereunder), all of which terms and provisions are made a part of and incorporated in this Agreement as
if they were each expressly set forth herein. Any capitalized term not defined in this Agreement shall have the same meaning as is ascribed
thereto in the Plan. The Participant hereby acknowledges receipt of a true copy of the Plan and that the Participant has read the Plan
carefully and fully understands its content. In the event of any conflict between the terms of this Agreement and the terms of the Plan,
the terms of the Plan shall control.

 

2. Grant
of SAR. The Company hereby grants to the Participant, as of the Grant Date, a SAR on the number of shares specified above. The
SAR represents the right, upon exercise, to receive [either cash or] a number of shares of Common Stock [, or a combination of cash and
shares of Common Stock,] with a Fair Market Value on the date of exercise equal [, in each case,] to the product of (i) the aggregate
number of shares with respect to which this SAR is exercised and (ii) the excess of (A) the Fair Market Value of a share of Common Stock
as of the date of exercise over (B) the SAR Base Price specified above. Except as otherwise provided by the Plan, the Participant agrees
and understands that nothing contained in this Agreement provides, or is intended to provide, the Participant with any protection against
potential future dilution of the Participant’s interest in the Company for any reason. The Participant shall have no rights as
a stockholder with respect to any shares of Common Stock covered by the SAR unless and until the Participant has become the holder of
record of such shares, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect
of any such shares, except as otherwise specifically provided for in the Plan or this Agreement.

 

     

     

    

 

3. Vesting
and Exercise.

 

(a) Vesting.
Subject to the provisions of Sections 3(b) and 3(c) hereof, the SAR shall vest and become exercisable as follows, provided that the Participant
has not incurred a Termination prior to each such vesting date:

 

	Vesting Date	 	 	Number of Shares	 
	[●]	 	 	[●]	 
	[●]	 	 	[●]	 
	[●]	 	 	[●]	 
	[●]	 	 	[●]	 

 

There
shall be no proportionate or partial vesting in the periods prior to each vesting date and all vesting shall occur only on the appropriate
vesting date, subject to the Participant’s continued service with the Company or any of its Subsidiaries on each applicable vesting
date. Upon expiration of the SAR, the SAR shall be cancelled and no longer exercisable.

 

(b) Committee
Discretion to Accelerate Vesting. Notwithstanding the foregoing, the Committee may, in its sole discretion, provide for accelerated
vesting of the SAR at any time and for any reason.

 

(c) [Termination
Following a Change in Control. Change in Control vesting provisions to be determined on a case-by-case basis by the Committee.]

 

(d) Expiration.
Unless earlier terminated in accordance with the terms and provisions of the Plan and/or this Agreement, all portions of the SAR (whether
vested or not vested) shall expire and shall no longer be exercisable after the expiration of ten (10) years from the Grant Date.

 

4. Termination.
Subject to the terms of the Plan and this Agreement, the SAR, to the extent vested at the time of the Participant’s Termination,
shall remain exercisable as follows:

 

(a) Termination
due to Death or Disability. In the event of the Participant’s Termination by reason of death or Disability, the vested portion
of the SAR shall remain exercisable until the earlier of (i) one (1) year from the date of such Termination, and (ii) the expiration
of the stated term of the SAR pursuant to Section 3(d) hereof; provided, however, that in the case of a Termination due
to Disability, if the Participant dies within such one (1) year exercise period, any unexercised SAR held by the Participant shall thereafter
be exercisable by the legal representative of the Participant’s estate, to the extent to which it was exercisable at the time of
death, for a period of one (1) year from the date of death, but in no event beyond the expiration of the stated term of the SAR pursuant
to Section 3(d) hereof.

 

    - 2 -

     

    

 

(b) Involuntary
Termination Without Cause. In the event of the Participant’s involuntary Termination by the Company without Cause, the vested
portion of the SAR shall remain exercisable until the earlier of (i) ninety (90) days from the date of such Termination, and (ii) the
expiration of the stated term of the SAR pursuant to Section 3(d) hereof.

 

(c) Voluntary
Resignation. In the event of the Participant’s voluntary Termination (other than a voluntary Termination described in Section
4(d) hereof), the vested portion of the SAR shall remain exercisable until the earlier of (i) ninety (90) days from the date of such
Termination, and (ii) the expiration of the stated term of the SAR pursuant to Section 3(d) hereof.

 

(d) Termination
for Cause. In the event of the Participant’s Termination for Cause or in the event of the Participant’s voluntary Termination
(as provided in Section 4(c) hereof) after an event that would be grounds for a Termination for Cause, the Participant’s entire
SAR (whether or not vested) shall terminate and expire upon such Termination.

 

(e) Treatment
of Unvested SAR upon Termination. Any portion of the SAR that is not vested as of the date of the Participant’s Termination
for any reason shall terminate and expire as of the date of such Termination.

 

5. Method
of Exercise. Subject to Section 8, to the extent that all or a portion of the SAR has become vested and exercisable, such portion
of the SAR may thereafter be exercised by the Participant, in whole or in part, at any time or from time to time prior to the expiration
of the SAR as provided herein and in accordance with Sections 7.4(c) and 7.4(d) of the Plan, including, without limitation, by the filing
of any written form of exercise notice as may be required by the Committee.

 

6. Non-Transferability.
The SAR, and any rights and interests with respect thereto, issued under this Agreement and the Plan shall not be sold, exchanged, transferred,
assigned or otherwise disposed of in any way by the Participant (or any beneficiary(ies) of the Participant), other than by testamentary
disposition by the Participant or the laws of descent and distribution. Any attempt to sell, exchange, transfer, assign, pledge, encumber
or otherwise dispose of or hypothecate in any way the SAR, or the levy of any execution, attachment or similar legal process upon the
SAR, contrary to the terms and provisions of this Agreement and/or the Plan shall be null and void and without legal force or effect.

 

7. Governing
Law. All questions concerning the construction, validity and interpretation of this Agreement shall be governed by, and construed
in accordance with, the laws of the State of Delaware, without regard to the choice of law principles thereof.

 

8. Withholding
of Tax. The Company shall have the power and the right to deduct or withhold, or require the Participant to remit to the Company,
an amount sufficient to satisfy any federal, state, local and foreign taxes of any kind (including, but not limited to, the Participant’s
FICA and SDI obligations) which the Company, in its sole discretion, deems necessary to be withheld or remitted to comply with the Code
and/or any other applicable law, rule or regulation with respect to the SAR and, if the Participant fails to do so, the Company may otherwise
refuse to issue or transfer any shares of Common Stock otherwise required to be issued pursuant to this Agreement. Any minimum statutorily
required withholding obligation with regard to the Participant may, with the consent of the Committee, be satisfied by reducing the amount
of cash or shares of Common Stock otherwise deliverable upon exercise of the SAR.

 

    - 3 -

     

    

 

9. Entire
Agreement; Amendment. This Agreement, together with the Plan, contains the entire agreement between the parties hereto with respect
to the subject matter contained herein, and supersedes all prior agreements or prior understandings, whether written or oral, between
the parties relating to such subject matter. The Committee shall have the right, in its sole discretion, to modify or amend this Agreement
from time to time in accordance with and as provided in the Plan. This Agreement may also be modified or amended by a writing signed
by both the Company and the Participant. The Company shall give written notice to the Participant of any such modification or amendment
of this Agreement as soon as practicable after the adoption thereof.

 

10. Notices.
Any notice hereunder by the Participant shall be given to the Company in writing and such notice shall be deemed duly given only upon
receipt thereof by the General Counsel of the Company. Any notice hereunder by the Company shall be given to the Participant in writing
and such notice shall be deemed duly given only upon receipt thereof at such address as the Participant may have on file with the Company.

 

11. No
Right to Employment. Any questions as to whether and when there has been a Termination and the cause of such Termination shall
be determined in the sole discretion of the Committee. Nothing in this Agreement shall interfere with or limit in any way the right of
the Company, its Subsidiaries or its Affiliates to terminate the Participant’s employment or service at any time, for any reason
and with or without Cause.

 

12. Transfer
of Personal Data. The Participant authorizes, agrees and unambiguously consents to the transmission by the Company (or any Subsidiary)
of any personal data information related to the SAR awarded under this Agreement for legitimate business purposes (including, without
limitation, the administration of the Plan). This authorization and consent is freely given by the Participant.

 

13. Compliance
with Laws. The issuance of this SAR (and any shares of Common Stock upon exercise of this SAR) pursuant to this Agreement shall
be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and
regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act and in each case any respective rules
and regulations promulgated thereunder) and any other law or regulation applicable thereto. The Company shall not be obligated to issue
the SAR or any of the shares pursuant to this Agreement if any such issuance would violate any such requirements.

 

14. Section
409A. Notwithstanding anything herein or in the Plan to the contrary, this SAR award is intended to be exempt from the applicable
requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent.

 

    - 4 -

     

    

 

15. Binding
Agreement; Assignment. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by the Company and its
successors and assigns. The Participant shall not assign (except in accordance with Section 6 hereof) any part of this Agreement without
the prior express written consent of the Company.

 

16. Headings.
The titles and headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not
be deemed to be a part of this Agreement.

 

17. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute
one and the same instrument.

 

18. Further
Assurances. Each party hereto shall do and perform (or shall cause to be done and performed) all such further acts and shall
execute and deliver all such other agreements, certificates, instruments and documents as either party hereto reasonably may request
in order to carry out the intent and accomplish the purposes of this Agreement and the Plan and the consummation of the transactions
contemplated thereunder.

 

19. Severability.
The invalidity or unenforceability of any provisions of this Agreement in any jurisdiction shall not affect the validity, legality or
enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of any provision of
this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable
to the fullest extent permitted by law.

 

20. Acquired
Rights. The Participant acknowledges and agrees that: (a) the Company may terminate or amend the Plan at any time; (b) the award
of the SAR made under this Agreement is completely independent of any other award or grant and is made at the sole discretion of the
Company; (c) no past grants or awards (including, without limitation, the SAR awarded hereunder) give the Participant any right to any
grants or awards in the future whatsoever; and (d) any benefits granted under this Agreement are not part of the Participant’s
ordinary salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation.

 

[Remainder
of Page Intentionally Left Blank]

 

    - 5 -

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

 

	 	SOMALOGIC, INC.
	 	 	 
	 	By:	                  
	 	Name:	 
	 	Title:	 
	 	 	 
	 	PARTICIPANT
	 	 	 
	 	By:	 
	 	Name: 	 
	 	Title:	 

 

 

- 6 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]